Free. Unsubscribe any time.
Centessa Pharmaceuticals plc (CNTA)
Centessa Pharmaceuticals plc filed 47 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 7 reporting owners, covering 62 transactions and 1,305,829 shares. None carries the SEC's AFF10B5ONE flag; all 47 name a plan in a footnote. 4 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-03-27, came 1 day after the one before it (2026-03-26) and reports 3 transactions against 3 in the filing before it.
- The sales it reports total 41,076 shares, 17,078 more than the 23,998 in the filing before it.
- Of the 10 companies the register lists beside it in its industry, 2 have more plan statements on file than it and 8 have fewer.
- Its 47 filings on file run from 2025-01-17 to 2026-03-27, and state 7 plan adoption dates, from 2024-05-16 to 2025-11-12.
Trades in Centessa Pharmaceuticals plc 62
- HUSSAIN IQBAL J — 2025-01-15 · S · 6,000 shares
- SAHA SAURABH — 2025-01-21 · S · 53,375 shares
- SAHA SAURABH — 2025-01-21 · S · 1,625 shares
- Weinhoff Gregory M — 2025-01-27 · S · 11,742 shares
- Anderson Karen M. — 2025-02-03 · S · 6,471 shares
- Bush Tia L — 2025-02-03 · S · 11,000 shares
- Anderson Karen M. — 2025-02-07 · S · 30,526 shares
- Anderson Karen M. — 2025-02-10 · S · 429 shares
- HUSSAIN IQBAL J — 2025-02-18 · S · 4,612 shares
- HUSSAIN IQBAL J — 2025-02-18 · S · 1,388 shares
- SAHA SAURABH — 2025-02-20 · S · 54,225 shares
- SAHA SAURABH — 2025-02-20 · S · 775 shares
Adoption dates in Centessa Pharmaceuticals plc 7
- 2024-05-16 — stated in 7 filings
- 2024-05-22 — stated in 7 filings
- 2024-09-13 — stated in 2 filings
- 2024-09-14 — stated in 17 filings
- 2024-11-14 — stated in 1 filing
- 2025-02-14 — stated in 7 filings
- 2025-11-12 — stated in 6 filings
Results prints in Centessa Pharmaceuticals plc 4
- 2025-03-24
- 2025-05-14
- 2025-08-12
- 2025-11-05
Trades before a print in Centessa Pharmaceuticals plc 1
- 4 days before the 2025-03-24 print — 2025-03-20 · S · SAHA SAURABH · 55,000 shares
- 7 days before the 2025-03-24 print — 2025-03-17 · S · CHAO DAVID M · 5,478 shares
- 7 days before the 2025-03-24 print — 2025-03-17 · S · CHAO DAVID M · 1,522 shares
- 7 days before the 2025-03-24 print — 2025-03-17 · S · HUSSAIN IQBAL J · 6,000 shares
- 9 days before the 2025-11-05 print — 2025-10-27 · S · Accardi Mario Alberto · 8,000 shares
- 13 days before the 2025-05-14 print — 2025-05-01 · S · HUSSAIN IQBAL J · 311 shares
- 14 days before the 2025-08-12 print — 2025-07-29 · S · Accardi Mario Alberto · 8,322 shares
- 16 days before the 2025-05-14 print — 2025-04-28 · S · HUSSAIN IQBAL J · 2,080 shares
- 18 days before the 2025-08-12 print — 2025-07-25 · S · Weinhoff Gregory M · 10,000 shares
- 19 days before the 2025-05-14 print — 2025-04-25 · S · HUSSAIN IQBAL J · 3,609 shares
- 19 days before the 2025-05-14 print — 2025-04-25 · S · Weinhoff Gregory M · 11,742 shares
- 21 days before the 2025-11-05 print — 2025-10-15 · S · HUSSAIN IQBAL J · 6,000 shares
Interval to Centessa Pharmaceuticals plc’s next reported results date
How the interval and sources are counted →
- 1within 5 days
- 5within 10 days
- 4shortest, days
- 16no later print
- CHAO DAVID M 2025-03-17 · S · 7 days before the 2025-03-24 print · Chief Administrative Officer
- CHAO DAVID M 2025-03-17 · S · 7 days before the 2025-03-24 print · Chief Administrative Officer
- HUSSAIN IQBAL J 2025-03-17 · S · 7 days before the 2025-03-24 print · General Counsel
- SAHA SAURABH 2025-03-20 · S · 4 days before the 2025-03-24 print · Chief Executive Officer
- Accardi Mario Alberto 2025-10-27 · S · 9 days before the 2025-11-05 print · President, Orexin Program
Adoption dates Centessa Pharmaceuticals plc states
- 2024-05-16 in 7 filings
- 2024-05-22 in 7 filings
- 2024-09-13 in 2 filings
- 2024-09-14 in 17 filings
- 2024-11-14 in 1 filing
- 2025-02-14 in 7 filings
- 2025-11-12 in 6 filings
Filing text: “10b5-1 trading plan adopted by the Reporting Person on February 14, 2025”
Reported results dates on file
- 2025-03-24
- 2025-05-14
- 2025-08-12
- 2025-11-05
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.